Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma (IFM 2012-03).

Arthur Bobin,Guillemette Fouquet,Alain Duhamel,Salomon Manier,Lionel Karlin,Brigitte Kolb,Mourad Tiab,Carla Araújo,Nathalie Meuleman,Jean-Valère Malfuson,Pascal Bourquard,Pascal Lenain,Arnaud Jaccard,Karim Belhadj,Michel Attal,Philippe Moreau,Hervé Avet-Loiseau,Cyrille Hulin,Thierry Facon,Xavier Leleu

Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma (IFM 2012-03).

2019

8029Background: Prolonged treatments have significantly improved survival in newly diagnosed multiple myeloma (NDMM). Lenalidomide (IMiDs), is currently approved in this indication, but remains a d...

Keywords:

Lenalidomide
Pathology
Carfilzomib
Oncology
Multiple myeloma
Internal medicine
Medicine
improved survival
newly diagnosed

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations